Modelling the cost of place of birth: a pathway analysis

被引:6
|
作者
Scarf, Vanessa L. [1 ]
Yu, Serena [2 ]
Viney, Rosalie [2 ]
Cheah, Seong Leang [1 ]
Dahlen, Hannah [3 ]
Sibbritt, David [1 ]
Thornton, Charlene [4 ]
Tracy, Sally [5 ]
Homer, Caroline [1 ,6 ]
机构
[1] Univ Technol Sydney, Fac Hlth, Ctr Midwifery Child & Family Hlth, POB 123 Broadway, Sydney, NSW 2007, Australia
[2] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia
[3] Western Sydney Univ, Sch Nursing & Midwifery, Sydney, NSW, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia
[6] Burnet Inst, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
Economic analysis; Childbirth; Cost; Homebirth; Birth centre; Decision tree; STANDARD MATERNITY CARE; LOW-RISK; WOMEN; EXPERIENCES; HOMEBIRTH; MIDWIVES; UNIT;
D O I
10.1186/s12913-021-06810-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background In New South Wales (NSW), Australia there are three settings available for women at low risk of complications to give birth: home, birth centre and hospital. Between 2000 and 2012, 93.6% of babies were planned to be born in hospital, 6.0% in a birth centre and 0.4% at home. Availability of alternative birth settings is limited and the cost of providing birth at home or in a birth centre from the perspective of the health system is unknown. Objectives The objective of this study was to model the cost of the trajectories of women who planned to give birth at home, in a birth centre or in a hospital from the public sector perspective. Methods This was a population-based study using linked datasets from NSW, Australia. Women included met the following selection criteria: 37-41 completed weeks of pregnancy, spontaneous onset of labour, and singleton pregnancy at low risk of complications. We used a decision tree framework to depict the trajectories of these women and Australian Refined-Diagnosis Related Groups (AR-DRGs) were applied to each trajectory to estimate the cost of birth. A scenario analysis was undertaken to model the cost for 30 000 women in one year. Findings 496 387 women were included in the dataset. Twelve potential outcome pathways were identified and each pathway was costed using AR-DRGs. An overall cost was also calculated by place of birth: $AUD4802 for homebirth, $AUD4979 for a birth centre birth and $AUD5463 for a hospital birth. Conclusion The findings from this study provides some clarity into the financial saving of offering more options to women seeking an alternative to giving birth in hospital. Given the relatively lower rates of complex intervention and neonatal outcomes associated with women at low risk of complications, we can assume the cost of providing them with homebirth and birth centre options could be cost-effective.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Birth Place: Simferopol
    Noack, Bernd
    [J]. THEATER HEUTE, 2019, (02): : 35 - 37
  • [22] SAFEST PLACE OF BIRTH
    BUTLER, NR
    GOLDING, J
    [J]. LANCET, 1979, 2 (8135): : 200 - 200
  • [23] SAFEST PLACE OF BIRTH
    SENN, SJ
    [J]. LANCET, 1979, 2 (8141): : 523 - 523
  • [24] birth-place
    Prescott, Holly
    [J]. FEMINIST REVIEW, 2009, (93) : 101 - 108
  • [25] SAFETY AND THE PLACE OF BIRTH
    YOUNG, G
    [J]. PRACTITIONER, 1993, 237 (1531) : 736 - &
  • [26] SAFEST PLACE OF BIRTH
    ALBERMAN, E
    EVANS, SJW
    [J]. LANCET, 1979, 2 (8138): : 358 - 358
  • [27] SAFEST PLACE OF BIRTH
    YUDKIN, PL
    REYNOLDS, JL
    BULL, MJV
    [J]. JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1989, 39 (320): : 126 - 126
  • [28] Commentary: The safest place of birth - Is there a better analysis than meta-analysis?
    Macfarlane, A
    [J]. BIRTH-ISSUES IN PERINATAL CARE, 1997, 24 (01): : 14 - 16
  • [29] Pathway variation analysis (PVA): Modelling and simulations
    Shukla, Nagesh
    Lahiri, Sudi
    Ceglarek, Darek
    [J]. OPERATIONS RESEARCH FOR HEALTH CARE, 2015, 6 : 61 - 77
  • [30] Ontological analysis and pathway modelling in drug discovery
    Zapatka M.
    Koch Y.
    Brors B.
    [J]. Pharmaceutical Medicine, 2008, 22 (2) : 99 - 105